跳至主要内容
临床试验/CTRI/2022/04/042006
CTRI/2022/04/042006尚未招募3 期

A non-inferiority randomized trial to assess the efficacy of 10mg hydroxyurea/kg/day versus 20mg hydroxyurea/kg/day in treatment of Sickle cell disease patients of tribal and non tribal areas in India.

ICMR Task Force0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Confirmed diagnosis of Sickle cell disease and not on hydroxyurea treatment for last 6 months.
  • 2.Age 2-14 years of age.
  • 3.Creatinine less than or equal to 1.4 mg/dl and/or estimated glomerular filtration rate greater than 45ml/min/1.73 m2
  • 4.Liver function tests (especially ALT and conjugated bilirubin) less than or equal to 4 times upper limit of normal.

排除标准

  • 1)Red blood cell transfusion in the last 3 months.
  • 2)Patient not willing to participate in the study.

研究者

发起方
ICMR Task Force

相似试验